Are outdated microbial identification methods risking your product safety and operational efficiency?
Join this webinar to unravel the complexities of microbial identification technologies and their pivotal role in fortifying contamination control strategies within the pharmaceutical industry.
Novo Nordisk to buy Cardior Pharmaceuticals
By Caroline Peachey (European Pharmaceutical Review)
UK advanced therapies to get £17.9 million boost
By Catherine Eckford (European Pharmaceutical Review)
Patient centricity for tailor-made healthcare
By European Pharmaceutical Review, Michal Davidescu PhD (Pfizer Pharmaceuticals Ltd)
FDA approves innovative gene therapy for MLD
By Catherine Eckford (European Pharmaceutical Review)
Patient centricity for tailor-made healthcare
By European Pharmaceutical Review, Michal Davidescu PhD (Pfizer Pharmaceuticals Ltd)
Validation of analytical procedures – ICH Q2(R2)
By Dave Elder (JPAG Member and David P Elder Consultancy)
Developing a new treatment paradigm for IgAN
By Catherine Eckford (European Pharmaceutical Review), Dr Marshall Fordyce (Vera…